Edition:
United States

Biohit Oyj (BIOBV.HE)

BIOBV.HE on Helsinki Stock Exchange

6.03EUR
11:29am EDT
Change (% chg)

€0.00 (+0.00%)
Prev Close
€6.03
Open
€6.05
Day's High
€6.05
Day's Low
€5.97
Volume
1,843
Avg. Vol
12,482
52-wk High
€6.85
52-wk Low
€4.71

BIOBV.HE

Chart for BIOBV.HE

About

Biohit Oyj is a Finland-based company engaged in the development, manufacture and marketing of diagnostic tests and analysis systems. The Company operates one business segment, named Diagnostics. The Diagnostics segment offers solutions for the early diagnosis and prevention of gastrointestinal diseases. It provides blood-sample... (more)
No analyst recommendations are available for BIOBV.HE.

Overall

Beta: 0.97
Market Cap(Mil.): €71.16
Shares Outstanding(Mil.): 11.80
Dividend: --
Yield (%): --

Financials

  BIOBV.HE Industry Sector
P/E (TTM): -- 13.97 18.98
EPS (TTM): -0.22 -- --
ROI: -30.43 -6.80 -5.09
ROE: -31.29 -6.26 -4.32

BRIEF-Chinmax Medical Systems to distribute Acetium Lozenge in China

* CHINMAX MEDICAL SYSTEMS INC. TO DISTRIBUTE ACETIUM® LOZENGE IN CHINA

Jun 05 2017

BRIEF-Biohit: results confirmed in a new trial of Acetium lozenge

* BIOHIT ACETIUM® LOZENGE IS A HIGHLY EFFECTIVE MEANS TO STOP SMOKING – RESULTS CONFIRMED IN A NEW LARGE-SCALE TRIAL

May 22 2017

BRIEF-Biohit H2 operating loss flat at EUR 1.3 mln

* H2 net sales 4.4 million euros ($4.67 million) versus 2.5 million euros year ago

Feb 20 2017

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.